Rotigotine transdermal patch
Rotigotine transdermal patch is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment
Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease
Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Clinical Trials (6)
Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment
Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease
Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6